Table 1.
Subject Characteristics (n = 673)
| Subjects (n, % female) | 673 (424, 63%) |
| Subjects with 2 or more DXA (n, % female) | 108 (68, 63%) |
| Median number of DXA scans (IQR) | 1 (1–1) |
| Median age at celiac diagnosis, y (IQR) | 10.6 (7.8–13.9) |
| Mean BMI-Z at initial DXA (SD) (n = 669) | −0.06 (1.09) |
| Mean BMI-Z at second DXA (SD) (n = 106) | 0.005 (0.891) |
| Median time between diagnosis and first DXA, d (IQR) | 0 (−11 to 31) |
| Median time between first and second DXA, y (IQR) | 2.3 (1.3–3.5) |
| Within 90 days of DXA 1 |
Within 90 days of DXA 2 |
|||||
|---|---|---|---|---|---|---|
| Laboratory values | n | Means | SD | n | Means | SD |
| 25-OH vitamin D, ng/mL | 559 | 37.9 | 12.0 | 98 | 40.6 | 13.0 |
| Albumin, g/dL | 505 | 4.5 | 0.4 | 97 | 4.6 | 0.3 |
| Calcium, mg/dL | 507 | 9.7 | 0.4 | 98 | 9.8 | 0.4 |
| Phosphorous, mg/dL | 43 | 4.7 | 0.7 | 7 | 5.0 | 0.9 |
| Alkaline phosphatase, U/L | 505 | 201.5 | 117.2 | 97 | 227.5 | 98.2 |
| Hemoglobin, g/dL | 516 | 13.3 | 1.1 | 99 | 13.4 | 1.0 |
| Tissue transglutaminase IgA, U | 460 | 112.6 | 57.3 | 53 | 42.8 | 52.9 |
| Tissue transglutaminase IgA, U/mL | 329 | 25.0 | 35.0 | 63 | 7.2 | 19.5 |